Movano (NASDAQ:MOVE) Share Price Crosses Above 200 Day Moving Average of $0.40

Movano Inc. (NASDAQ:MOVE)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.40 and traded as high as $0.40. Movano shares last traded at $0.37, with a volume of 132,982 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Benchmark restated a “speculative buy” rating and set a $2.00 price target on shares of Movano in a report on Wednesday, September 4th.

Movano Stock Down 5.0 %

The company has a market cap of $36.75 million, a PE ratio of -0.67 and a beta of 0.09. The stock has a 50-day simple moving average of $0.35 and a 200 day simple moving average of $0.40.

Movano (NASDAQ:MOVE) last announced its earnings results on Wednesday, August 14th. The technology company reported ($0.06) earnings per share (EPS) for the quarter.

Institutional Trading of Movano

Large investors have recently modified their holdings of the stock. Dorsey & Whitney Trust CO LLC increased its holdings in shares of Movano by 50.0% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,630,084 shares of the technology company’s stock valued at $1,548,000 after acquiring an additional 1,876,000 shares during the last quarter. Quantum Private Wealth LLC raised its position in Movano by 113.8% in the second quarter. Quantum Private Wealth LLC now owns 89,139 shares of the technology company’s stock worth $25,000 after acquiring an additional 47,441 shares in the last quarter. Mirador Capital Partners LP grew its position in Movano by 9.6% during the first quarter. Mirador Capital Partners LP now owns 413,204 shares of the technology company’s stock worth $170,000 after buying an additional 36,230 shares during the period. Finally, EP Wealth Advisors LLC purchased a new position in Movano in the 4th quarter valued at approximately $101,000. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Movano Company Profile

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.